Jefferies Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.4M	Buy	468,146 +1,128	+0.2%	+$65.8K	0.32%	89
2025 Q4	$27.8M	Buy	+467,018	New	+$25.4M	0.23%	140
2025 Q2	–	Sell	-6,169	Closed	-$436K	–	1327
2025 Q1	$436K	Buy	+6,169	New	+$415K	0.01%	1086
2024 Q4	–	Sell	-4,350	Closed	-$306K	–	1609
2024 Q3	$306K	Buy	+4,350	New	+$364K	0.01%	1111
2024 Q2	–	Sell	-10,600	Closed	-$926K	–	1442
2024 Q1	$926K	Buy	10,600 +379	+4%	+$33.9K	0.02%	850
2023 Q4	$986K	Buy	10,221 +7,231	+242%	+$640K	0.02%	958
2023 Q3	$265K	Sell	2,990 -2,023	-40%	-$180K	0.01%	1261
2023 Q2	$435K	Sell	5,013 -22,904	-82%	-$2.16M	0.01%	1224
2023 Q1	$2.71M	Sell	27,917 -17,855	-39%	-$1.85M	0.06%	555
2022 Q4	$4.74M	Buy	+45,772	New	+$4.3M	0.08%	417